To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...
High-resolution structures explain the mechanism of human PNPase and provide insights into mutations causing hereditary hearing loss and neurological ...
To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most genetic medicine uses ...
Rona Therapeutics, a clinical-stage RNAi company, today announced the recent completion of Cohort 1 dosing in its Phase 1 first-in-human clinical study of RN3161, an investigational GalNAc-conjugated ...
ORR achieved in second-line KRAS-mutant MSS colorectal cancer—triple historical response rates for Avastin + FOLFIRI of 6-11%Translational analysis shows pelareorep enhances KRAS-mutant–specific ...
Morning Overview on MSN
AI helped scientists stop a virus with 1 tiny tweak
Artificial intelligence has just helped virologists pull off something that used to take years of trial and error: crippling ...
A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...
RFdiffusion2, RFdiffusion3, and Riff-Diff each solve different structural problems in computational enzyme design ...
There are strategic intellectual property considerations at every stage of a brand’s development. Ranjan Narula, Aditi Roy Chowdhury, and Simran Singh of RNA, Technology and IP Attorneys outline how ...
Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced it will participate in the ...
Canaan has been steadily investing in renewable energy projects, with a gas-to-computing pilot in Canada and a deal to deploy miners at a wind-powered data center in Texas. Bitcoin mining and hardware ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results